As of May 31, 2025, Manitex Capital Inc (MNX.V) reports a ROE (Return on Equity) of 2.69%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Manitex Capital Inc's ROE (Return on Equity)
Over recent years, Manitex Capital Inc's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2023-10-31 | 2.69% |
| 2022-10-31 | -78.47% |
| 2021-10-31 | -24.60% |
| 2020-10-31 | 19.47% |
| 2019-10-31 | 56.72% |
This slight downward trend highlights how Manitex Capital Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Manitex Capital Inc's ROE (Return on Equity) to Peers
To better understand Manitex Capital Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Manitex Capital Inc (MNX.V) | 2.69% |
| Fuse Medical Inc (FZMD) | 269.39% |
| Millennium Healthcare Inc (MHCC) | 115.59% |
| Union Bridge Holdings Ltd (UGHL) | 70.47% |
| Global Pharm Holdings Group Inc (GPHG) | 63.26% |
| Galileo Life Sciences Inc (MDRM) | 37.21% |
Compared to its competitors, Manitex Capital Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.